Arix Bioscience plc, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 757,310 shares at $21.33 ($16.2M) on 2020-05-28, disclosed to the SEC on 2020-05-29.
Open-market sale of $16.2M HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.39 | 12,064 | $270K | 1.7% |
| 2 | $22.39 | 12,064 | $270K | 1.7% |
| 3 | $21.33 | 366,591 | $7.8M | 48.3% |
| 4 | $21.33 | 366,591 | $7.8M | 48.3% |
| Total | $21.36 avg | 757,310 | $16.2M | 100% |
| Filing → |
| HARP | BUY | 2019-02-14 | $6.0M | — | Filing → |
| LOGC | BUY | 2018-10-26 | $7.0M | — | Filing → |